Literature DB >> 15163418

PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets.

Torsten W Remmerbach1, Ute G Brinckmann, Alexander Hemprich, M Chekol, K Kühndel, Uwe Gerd Liebert.   

Abstract

BACKGROUND AND OBJECTIVES: Human papillomaviruses (HPV) are the causal agent for the development of carcinomas in the cervix uteri and further pathological changes of the skin including mucosa, particularly warts, condylomas and dysplasias. Therefore, we investigated the efficacy of different consensus primers pairs for HPV detection by PCR using brushed samples from the oral cavity in comparison with samples from the cervix uteri. STUDY
DESIGN: In the present study, we used two well-established sets of PCR primers in different combinations for the detection of HPV DNA in 106 non-invasive brush biopsy samples of the oral mucosa and 56 samples from the cervix uteri. Direct sequencing of PCR products in all cases determined HPV genotype and specificity.
RESULTS: Overall, HPV was detected in 69 of 106 oral mucosa samples. HPV specific amplicons were obtained in 35.8% (N = 38) when using GP5+/6+ primers. The positivity rate was increased to 65.1% in a GP5+/6+ auto-nested PCR approach. In contrast, MY9/11 PCR and nested PCR with MY9/11 outer followed by GP5+/6+ inner primers yielded 2.2% and 16.1%, respectively. In gynaecological samples, PCR results were similar independent of the primer combination used. Thus, DNA quality and DNA content could be additional factors influencing the rate of positivity.
CONCLUSION: For oral mucosa samples, auto-nested GP5+/6+ PCR is in our hands the most suitable approach for epidemiological studies because of its high sensitivity, high reliability and reproducibility as well as its relatively simple laboratory procedure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163418     DOI: 10.1016/j.jcv.2003.12.011

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  33 in total

1.  Evaluation of different techniques for identification of human papillomavirus types of low prevalence.

Authors:  Ivan Sabol; Martina Salakova; Jana Smahelova; Michal Pawlita; Markus Schmitt; Nina Milutin Gasperov; Magdalena Grce; Ruth Tachezy
Journal:  J Clin Microbiol       Date:  2008-03-05       Impact factor: 5.948

2.  Prevalence of HPV infection in head and neck carcinomas shows geographical variability: a comparative study from Brazil and Germany.

Authors:  Franziska Hauck; Michelle Oliveira-Silva; Johannes H Dreyer; Victor José Ferreira Perrusi; Roberto Alfonso Arcuri; Rocio Hassan; Cibele Rodrigues Bonvicino; Mario Henrique M Barros; Gerald Niedobitek
Journal:  Virchows Arch       Date:  2015-03-28       Impact factor: 4.064

3.  SLPI and AnxA2 expression in neoplasm-free palatine tonsils is associated with smoking habit of individuals.

Authors:  Elgar S Quabius; Berit Bögershausen; Lukas Getzin; Tibor Görögh; Maximilian P Gebhard; Anna S Hoffmann; Markus Hoffmann
Journal:  Mol Clin Oncol       Date:  2017-07-24

Review 4.  HPV detection methods in head and neck cancer.

Authors:  Aldo Venuti; Francesca Paolini
Journal:  Head Neck Pathol       Date:  2012-07-03

5.  Tonsillar swabs and sputum predict SLPI- and AnxA2 expression in tonsils: A prospective study on smoking dependent SLPI- and AnxA2-expression, and tonsillar HPV infection.

Authors:  Elgar Susanne Quabius; Alessa Heinrichs; André Kühnel; Martin Laudien; Florian Hoppe; Robert Mlynski; Petra Ambrosch; Markus Hoffmann
Journal:  Oncol Lett       Date:  2022-03-28       Impact factor: 2.967

6.  Specificity of L1 peptides versus virus-like particles for detection of human papillomavirus-positive cervical lesions in females attending Engativa Hospital, Bogota, Colombia.

Authors:  Mauricio Urquiza; Ricardo Sánchez; Jairo Amaya; Sandra León; Jenny Acosta; Manuel A Patarroyo; Milena Camargo; Manuel E Patarroyo
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

7.  Single-tube seminested PCR assay for detecting human papillomavirus in clinical samples.

Authors:  Rajan Saini; Jacinta Santhanam; Nor Hayati Othman; Deepti Saini; Thean-Hock Tang
Journal:  Open Microbiol J       Date:  2009-07-22

Review 8.  HPV & head and neck cancer: a descriptive update.

Authors:  Peter K C Goon; Margaret A Stanley; Jörg Ebmeyer; Lars Steinsträsser; Tahwinder Upile; Waseem Jerjes; Manuel Bernal-Sprekelsen; Martin Görner; Holger H Sudhoff
Journal:  Head Neck Oncol       Date:  2009-10-14

9.  Sensitive HPV detection in oropharyngeal cancers.

Authors:  David M Winder; Siolian L R Ball; Katie Vaughan; Nashat Hanna; Yin Ling Woo; Jürgen-Theodor Fränzer; Jane C Sterling; Margaret A Stanley; Holger Sudhoff; Peter K C Goon
Journal:  BMC Cancer       Date:  2009-12-15       Impact factor: 4.430

10.  Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor.

Authors:  Markus Hoffmann; Elgar S Quabius; Silke Tribius; Lena Hebebrand; Tibor Görögh; Gordana Halec; Tomas Kahn; Jürgen Hedderich; Christoph Röcken; Jochen Haag; Tim Waterboer; Markus Schmitt; Anna R Giuliano; W Martin Kast
Journal:  Oncol Rep       Date:  2013-03-05       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.